Veterans Aging Cohort Study Index as a Marker of Bone Disease in HIV-Infected Patients

Lokesh Shahani1,2, Katharine Breaux1,2, Michael Lin3

  • 1The Section of Infectious Diseases, The Michael E. DeBakey VA Medical Center, Houston, Texas.

Insights

The Veterans Aging Cohort Study (VACS) Index can help identify human immunodeficiency virus (HIV)-infected patients at risk for low bone mineral density (BMD). This index may aid in screening for low BMD in settings lacking dual-energy X-ray absorptiometry (DXA) scans.

Area of Science:

  • Medical research
  • Bone health
  • Infectious diseases

Background:

  • People with HIV have a higher risk of low bone mineral density (BMD) and fractures.
  • Early identification of low BMD in HIV patients is crucial for fracture prevention.

Purpose of the Study:

  • To investigate if the HIV-specific Veterans Aging Cohort Study (VACS) Index can identify patients at risk for low BMD.
  • To explore the association between VACS Index components and low BMD.

Main Methods:

  • Retrospective study of 195 HIV-infected patients with dual-energy X-ray absorptiometry (DXA) scans.
  • Calculation of VACS Index using laboratory values near DXA scan date.
  • Logistic regression analysis to assess the association between VACS Index and low BMD, adjusting for confounders.

Main Results:

  • 56% of patients had low BMD.
  • VACS Index score was significantly associated with low BMD (OR 1.21 per 10-unit increase).
  • Hepatitis C coinfection was strongly associated with increased risk of low BMD (OR 24.4).

Conclusions:

  • The VACS Index is a significant marker for low BMD risk in HIV-infected patients.
  • The VACS Index can potentially be used to develop a screening tool for low BMD.
  • This tool could be valuable in resource-limited settings where DXA scans are unavailable.

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
191
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
230
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
234
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
199
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
243
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
630